HCP Treatment Decision-Making Research: A Comprehensive Overview
Healthcare providers (HCP) treatment decision-making research, sometimes called “buying process” or “barriers-and-drivers” studies, provides client teams with a foundational understanding of HCPs’ preferences and reasoning process in selecting specific treatments in a designated therapeutic category.
This research is instrumental in identifying the core aspects that HCPs consider when making treatment recommendations.
Our approach to HCP treatment decision-making studies typically involves 2 study phases. Each phase involves 1-on-1 qualitative interviews with the relevant HCP. This method allows for in-depth exploration of HCPs’ perspectives and reasoning.
Phase 1 involves eliciting HCPs’ cultural and conceptual models of diagnosis and treatment decision-making. By tapping into their beliefs and experiences, we can better understand how they arrive at their treatment choices.
From these findings, we generate treatment decision-making maps, which we present to HCPs for feedback and refinement in phase 2 research. This iterative process ensures that the maps accurately reflect the complexities of HCPs’ decision-making frameworks.
Moreover, these maps serve as a valuable tool for visualizing the different pathways that HCPs may take in their treatment decision-making process. They illustrate the various influences, including clinical evidence, patient characteristics, and other external factors, which can guide or hinder their decisions. By presenting these insights, we aim to foster a deeper understanding of treatment preferences within the healthcare community.
We believe that our background in psychological and cultural anthropology heightens our ability to elicit and identify the organization of the shared conceptual models underlying HCPs’ decision-making. This unique perspective allows us to delve deeper into the motivations and values that drive HCPs in their treatment choices.
As part of the second phase, we determine the relative frequency of decision-making branches in the treatment maps. This analysis provides insights into the most common pathways that HCPs take when considering treatment options.